Skip to main content
Top
Published in: Gastric Cancer 1/2015

01-01-2015 | Review Article

Obesity and related risk factors in gastric cardia adenocarcinoma

Authors: Sidney Olefson, Steven F. Moss

Published in: Gastric Cancer | Issue 1/2015

Login to get access

Abstract

Over recent decades, the incidence of cancers of the gastroesophageal junction, including gastric cardia tumors, has increased markedly. This is a trend that has been well documented, especially in studies from the USA and northern Europe that have also demonstrated a concomitant rise in the ratio of cardia to distal gastric cancers. The rise in the prevalence of gastric cardia adenocarcinoma has been paralleled by the worldwide obesity epidemic, with almost all epidemiological studies reporting increased body mass index and obesity increase the risk of cardia cancer development. However, the strength of this association is less marked than the link between obesity and esophageal adenocarcinoma, and the mechanisms remain poorly understood. Other possible confounders of the relationship between obesity and cardia cancer include the decline in Helicobacter pylori infection and the widespread use of proton pump inhibitors, although these have rarely been controlled for in case–control and cohort studies investigating associations between obesity and cardia cancer. We review these epidemiological trends and discuss proposed mechanisms for the association, drawing attention to controversies over the difficulty of defining cardia cancer. The relative paucity of high-quality epidemiological studies from other regions of the world should prompt further investigation of this issue, especially in populations undergoing rapid socioeconomic change.
Literature
2.
go back to reference Anderson W, Camargo MC, Fraumeni JF, Correa P, Rosenberg PS, Rabkin CS. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA. 2010;303:1723–8.PubMedCentralPubMedCrossRef Anderson W, Camargo MC, Fraumeni JF, Correa P, Rosenberg PS, Rabkin CS. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA. 2010;303:1723–8.PubMedCentralPubMedCrossRef
3.
go back to reference Dubecz A, Solymosi N, Stadlhuber RJ, Schweigert M, Stein HJ, Peters JH. Does the incidence of adenocarcinoma of the esophagus and gastric cardia continue to rise in the twenty-first century?—a SEER database analysis. J Gastrointest Surg. 2013;18:124–9.CrossRef Dubecz A, Solymosi N, Stadlhuber RJ, Schweigert M, Stein HJ, Peters JH. Does the incidence of adenocarcinoma of the esophagus and gastric cardia continue to rise in the twenty-first century?—a SEER database analysis. J Gastrointest Surg. 2013;18:124–9.CrossRef
5.
go back to reference Fock KM. Review Article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther. 2014;40:250–60.PubMedCrossRef Fock KM. Review Article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther. 2014;40:250–60.PubMedCrossRef
7.
go back to reference Deans C, Yeo MSW, Soe MY, Shabbir A, Ti TK, So JBY. Cancer of the gastric cardia is rising in incidence in an Asian population and is associated with adverse outcome. World J Surg. 2011;35:617–24.PubMedCrossRef Deans C, Yeo MSW, Soe MY, Shabbir A, Ti TK, So JBY. Cancer of the gastric cardia is rising in incidence in an Asian population and is associated with adverse outcome. World J Surg. 2011;35:617–24.PubMedCrossRef
8.
go back to reference Turner JR. The gastrointestinal tract. In: Kumar V, Abbas AK, Fausto N, Aster JC, editors. Robbins and Cotran pathologic basis of disease. 8th ed. Philadelphia: Saunders; 2010. p. 763–831.CrossRef Turner JR. The gastrointestinal tract. In: Kumar V, Abbas AK, Fausto N, Aster JC, editors. Robbins and Cotran pathologic basis of disease. 8th ed. Philadelphia: Saunders; 2010. p. 763–831.CrossRef
9.
go back to reference Chandrasoma PT, Lokuhetty DM, Demeester TR, Bremmer CG, Peters JH, Oberg S, et al. Definition of histopathologic changes in gastroesophageal reflux disease. Am J Surg Pathol. 2000;24:344–51.PubMedCrossRef Chandrasoma PT, Lokuhetty DM, Demeester TR, Bremmer CG, Peters JH, Oberg S, et al. Definition of histopathologic changes in gastroesophageal reflux disease. Am J Surg Pathol. 2000;24:344–51.PubMedCrossRef
10.
go back to reference Kilgore SP, Ormsby AH, Gramlich TL, Rice TW, Richter JE, Falk GW, et al. The gastric cardia: fact or fiction? Am J Gastroenterol. 2000;95:921–4.PubMedCrossRef Kilgore SP, Ormsby AH, Gramlich TL, Rice TW, Richter JE, Falk GW, et al. The gastric cardia: fact or fiction? Am J Gastroenterol. 2000;95:921–4.PubMedCrossRef
11.
go back to reference Glickman JN Fox, Fox V, Antonioli DA, Wang HH, Odze RD. Morphology of the cardia and significance of carditis in pediatric patients. Am J Surg Pathol. 2002;26:1032–9.PubMedCrossRef Glickman JN Fox, Fox V, Antonioli DA, Wang HH, Odze RD. Morphology of the cardia and significance of carditis in pediatric patients. Am J Surg Pathol. 2002;26:1032–9.PubMedCrossRef
12.
go back to reference Hertogh GD, Van Eyken P, Ectors N, Tack J, Geboes K. On the existence and location of cardiac mucosa: an autopsy study in embryos, fetuses, and infants. Gut. 2003;52:791–6.PubMedCentralPubMedCrossRef Hertogh GD, Van Eyken P, Ectors N, Tack J, Geboes K. On the existence and location of cardiac mucosa: an autopsy study in embryos, fetuses, and infants. Gut. 2003;52:791–6.PubMedCentralPubMedCrossRef
13.
14.
go back to reference Mariette C. Oesophagogastric junction adenocarcinoma: which therapeutic approach? Lancet Oncol. 2011;12:296–305.PubMedCrossRef Mariette C. Oesophagogastric junction adenocarcinoma: which therapeutic approach? Lancet Oncol. 2011;12:296–305.PubMedCrossRef
15.
go back to reference Edge SB. AJCC cancer staging handbook: from the AJCC cancer staging manual. 7th ed. New York: Springer; 2010. Edge SB. AJCC cancer staging handbook: from the AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
16.
go back to reference Derakhshan MH, Malekzadeh R, Watabe H, Yazdanbod A, Fyfe V, Kazemi A, et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut. 2008;57:298–305.PubMedCrossRef Derakhshan MH, Malekzadeh R, Watabe H, Yazdanbod A, Fyfe V, Kazemi A, et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut. 2008;57:298–305.PubMedCrossRef
17.
go back to reference Wijetunge S, Ma Y, DeMeester S, Hagen J, Demeester T, Chandrosoma P. Association of adenocarcinomas of the distal esophagus, gastroesophageal junction, and gastric cardia with gastric pathology. Am J Surg Pathol. 2010;32:1521–7.CrossRef Wijetunge S, Ma Y, DeMeester S, Hagen J, Demeester T, Chandrosoma P. Association of adenocarcinomas of the distal esophagus, gastroesophageal junction, and gastric cardia with gastric pathology. Am J Surg Pathol. 2010;32:1521–7.CrossRef
18.
go back to reference Oh DS, Demeester SR, Tanaka K, Marjoram P, Kuramochi H, Vallbohmer D, et al. The gene expression profile of cardia intestinal metaplasia is similar to that of Barrett’s esophagus, not gastric intestinal metaplasia. Dis Esophagus. 2011;24:516–22.PubMedCrossRef Oh DS, Demeester SR, Tanaka K, Marjoram P, Kuramochi H, Vallbohmer D, et al. The gene expression profile of cardia intestinal metaplasia is similar to that of Barrett’s esophagus, not gastric intestinal metaplasia. Dis Esophagus. 2011;24:516–22.PubMedCrossRef
20.
go back to reference McColl KEL, Going JJ. Aetiology and classification of adenocarcinoma of the gastro-oesophageal junction/cardia. Gut. 2010;59:282–4.PubMedCrossRef McColl KEL, Going JJ. Aetiology and classification of adenocarcinoma of the gastro-oesophageal junction/cardia. Gut. 2010;59:282–4.PubMedCrossRef
21.
go back to reference Ji BT, Chow WH, Yang G, McLaughlin JK, Gao RN, Zheng W, et al. Body mass index and the risk of cancers of the gastric cardia and distal stomach in Shanghai, China. Cancer Epidemiol Biomarkers Prev. 1997;6:481–5.PubMed Ji BT, Chow WH, Yang G, McLaughlin JK, Gao RN, Zheng W, et al. Body mass index and the risk of cancers of the gastric cardia and distal stomach in Shanghai, China. Cancer Epidemiol Biomarkers Prev. 1997;6:481–5.PubMed
22.
go back to reference Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998;90:150–5.PubMedCrossRef Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998;90:150–5.PubMedCrossRef
23.
go back to reference Lagergren J, Bergström R, Olof N. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999;130:883–90.PubMedCrossRef Lagergren J, Bergström R, Olof N. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999;130:883–90.PubMedCrossRef
24.
go back to reference Tran GD. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. J Cancer. 2005;113:456–63. Tran GD. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. J Cancer. 2005;113:456–63.
25.
go back to reference Lindblad M, Rodríguez LA, Lagergren J. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control. 2005;16:285–94. Lindblad M, Rodríguez LA, Lagergren J. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control. 2005;16:285–94.
26.
go back to reference Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control. 2006;17:901–9.PubMedCrossRef Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control. 2006;17:901–9.PubMedCrossRef
27.
go back to reference Merry AHH, Schouten LJ, Goldbohm RA, van den Brandt PA. Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study. Gut. 2007;56:1503–11.PubMedCentralPubMedCrossRef Merry AHH, Schouten LJ, Goldbohm RA, van den Brandt PA. Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study. Gut. 2007;56:1503–11.PubMedCentralPubMedCrossRef
28.
go back to reference Corley DA, Kubo A, Zhao W. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev. 2008;17:352–8.PubMedCentralPubMedCrossRef Corley DA, Kubo A, Zhao W. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev. 2008;17:352–8.PubMedCentralPubMedCrossRef
29.
go back to reference Abnet CC, Freedman ND, Hollenbeck AR, Fraumeni JF Jr, Leitzmann M, Schatzkin A. A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. Eur J Cancer. 2008;44:465–71.PubMedCentralPubMedCrossRef Abnet CC, Freedman ND, Hollenbeck AR, Fraumeni JF Jr, Leitzmann M, Schatzkin A. A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. Eur J Cancer. 2008;44:465–71.PubMedCentralPubMedCrossRef
30.
go back to reference Wu AH, Wan P, Bernstein L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control. 2001;12:721–32.PubMedCrossRef Wu AH, Wan P, Bernstein L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control. 2001;12:721–32.PubMedCrossRef
31.
go back to reference Ryan AM, Rowley SP, Fitzgerald AP, Ravi N, Reynolds JV. Adenocarcinoma of the oesophagus and gastric cardia: male preponderance in association with obesity. Eur J Cancer. 2006;42:1151–8.PubMedCrossRef Ryan AM, Rowley SP, Fitzgerald AP, Ravi N, Reynolds JV. Adenocarcinoma of the oesophagus and gastric cardia: male preponderance in association with obesity. Eur J Cancer. 2006;42:1151–8.PubMedCrossRef
32.
go back to reference Turati F, Tramacere I, La Vecchia C, Negri E. A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma. Ann Oncol. 2013;24:609–17.PubMedCrossRef Turati F, Tramacere I, La Vecchia C, Negri E. A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma. Ann Oncol. 2013;24:609–17.PubMedCrossRef
33.
go back to reference O’Doherty MG, Freedman ND, Hollenbeck AR, Schatzkin A, Abnet CC. A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH–AARP diet and health study. Gut. 2012;61:1261–8.PubMedCentralPubMedCrossRef O’Doherty MG, Freedman ND, Hollenbeck AR, Schatzkin A, Abnet CC. A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH–AARP diet and health study. Gut. 2012;61:1261–8.PubMedCentralPubMedCrossRef
34.
go back to reference Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–31.PubMedCrossRef Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–31.PubMedCrossRef
35.
go back to reference Wu AH, Tseng CC, Bernstein L. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer. 2003;98:940–8.PubMedCrossRef Wu AH, Tseng CC, Bernstein L. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer. 2003;98:940–8.PubMedCrossRef
36.
go back to reference Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95:1404–13.PubMedCrossRef Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95:1404–13.PubMedCrossRef
37.
go back to reference Garcia Rodriguez LA, Lagergren J, Lindblad M. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut. 2006;55:1538–44.PubMedCrossRef Garcia Rodriguez LA, Lagergren J, Lindblad M. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut. 2006;55:1538–44.PubMedCrossRef
38.
go back to reference Poulsen AH, Christensen S, McLaughlin JK, Thomsen RW, Sørensen HT, Olsen JH, et al. Proton pump inhibitors and risk of gastric cancer: a population-based cohort study. Br J Cancer. 2009;100:1503–7.PubMedCentralPubMedCrossRef Poulsen AH, Christensen S, McLaughlin JK, Thomsen RW, Sørensen HT, Olsen JH, et al. Proton pump inhibitors and risk of gastric cancer: a population-based cohort study. Br J Cancer. 2009;100:1503–7.PubMedCentralPubMedCrossRef
41.
go back to reference Neale RE, Doecke JD, Pandeya N, Sadeghi S, Green AC, Webb PM, et al. Does type 2 diabetes mellitus influence the risk of oesophageal adenocarcinoma? Br J Cancer. 2009;100:1514.PubMedCentralCrossRef Neale RE, Doecke JD, Pandeya N, Sadeghi S, Green AC, Webb PM, et al. Does type 2 diabetes mellitus influence the risk of oesophageal adenocarcinoma? Br J Cancer. 2009;100:1514.PubMedCentralCrossRef
42.
go back to reference Lin SW, Freedman ND, Hollenbeck AR, Schatzkin A, Abnet CC. Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers. Cancer Epidemiol Biomarkers Prev. 2011;20:954–61.PubMedCentralPubMedCrossRef Lin SW, Freedman ND, Hollenbeck AR, Schatzkin A, Abnet CC. Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers. Cancer Epidemiol Biomarkers Prev. 2011;20:954–61.PubMedCentralPubMedCrossRef
44.
go back to reference Stevens J, Schouten LJ, Goldbohm RA, van den Brandt PA. Vegetables and fruits consumption and risk of esophageal and gastric cancer subtypes in the Netherlands cohort study. Int J Cancer. 2011;129:2681–93.CrossRef Stevens J, Schouten LJ, Goldbohm RA, van den Brandt PA. Vegetables and fruits consumption and risk of esophageal and gastric cancer subtypes in the Netherlands cohort study. Int J Cancer. 2011;129:2681–93.CrossRef
45.
go back to reference Lunet N, Valbuena C, Vieira AL, Lopes C, Lopes C, David L, et al. Fruit and vegetable consumption and gastric cancer by location and histological type: case–control and meta-analysis. Eur J Cancer Prev. 2007;16:312–27.PubMedCrossRef Lunet N, Valbuena C, Vieira AL, Lopes C, Lopes C, David L, et al. Fruit and vegetable consumption and gastric cancer by location and histological type: case–control and meta-analysis. Eur J Cancer Prev. 2007;16:312–27.PubMedCrossRef
46.
go back to reference Terry P, Hansen H, Wolk A, Nyrén O. Fruit and vegetable consumption in the prevention of oesophageal and cardia cancer. Eur J Cancer Prev. 2001;10:365–9.PubMedCrossRef Terry P, Hansen H, Wolk A, Nyrén O. Fruit and vegetable consumption in the prevention of oesophageal and cardia cancer. Eur J Cancer Prev. 2001;10:365–9.PubMedCrossRef
47.
go back to reference Navarro S, Stephanie A, Mayne ST, Risch H, Gammon MD, Vaughan TL, et al. Food group intake and risk of subtypes of esophageal and gastric cancer. Int J Cancer. 2008;123:852–60.CrossRef Navarro S, Stephanie A, Mayne ST, Risch H, Gammon MD, Vaughan TL, et al. Food group intake and risk of subtypes of esophageal and gastric cancer. Int J Cancer. 2008;123:852–60.CrossRef
48.
go back to reference Bertuccio P, Rosato V, Andreano A, Ferraroni M, Decarli A, Edefonti V, et al. Dietary patterns and gastric cancer risk: a systematic review and meta-analysis. Ann Oncol. 2013;24:1450–8.PubMedCrossRef Bertuccio P, Rosato V, Andreano A, Ferraroni M, Decarli A, Edefonti V, et al. Dietary patterns and gastric cancer risk: a systematic review and meta-analysis. Ann Oncol. 2013;24:1450–8.PubMedCrossRef
49.
go back to reference Bingham SA. Limitations of the various methods for collecting dietary intake data. Ann Nutr Metab. 1991;35:117–27.PubMedCrossRef Bingham SA. Limitations of the various methods for collecting dietary intake data. Ann Nutr Metab. 1991;35:117–27.PubMedCrossRef
51.
go back to reference IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. A review of human carcinogens: biological agents. Vol. 100. Geneva: WHO Press; 2009. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. A review of human carcinogens: biological agents. Vol. 100. Geneva: WHO Press; 2009.
52.
go back to reference Kamangar F, Dawsey SM, Blaser MJ. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst. 2006;98:1445–52.PubMedCrossRef Kamangar F, Dawsey SM, Blaser MJ. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst. 2006;98:1445–52.PubMedCrossRef
53.
go back to reference Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res. 2008;1:329–38.CrossRef Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res. 2008;1:329–38.CrossRef
54.
go back to reference Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 1998;58:588–90.PubMed Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 1998;58:588–90.PubMed
55.
go back to reference Queiroz DMM, Rocha AMC, Crabtree JE. Unintended consequences of Helicobacter pylori infection in children in developing countries: iron deficiency, diarrhea and growth retardation. Gut Microbes. 2013;4:42–3.CrossRef Queiroz DMM, Rocha AMC, Crabtree JE. Unintended consequences of Helicobacter pylori infection in children in developing countries: iron deficiency, diarrhea and growth retardation. Gut Microbes. 2013;4:42–3.CrossRef
56.
go back to reference Mera RM, Correa P, Fontham EE, Reina JC, Pradilla A, Alzate A, et al. Effects of a new Helicobacter pylori infection on height and weight in Colombian children. Ann Epidemiol. 2006;16:347.PubMedCrossRef Mera RM, Correa P, Fontham EE, Reina JC, Pradilla A, Alzate A, et al. Effects of a new Helicobacter pylori infection on height and weight in Colombian children. Ann Epidemiol. 2006;16:347.PubMedCrossRef
57.
go back to reference Ioannou GN, Weiss NS, Kearney DJ. Is Helicobacter pylori seropositivity related to body mass index in the United States? Aliment Pharmacol Ther. 2005;21:765–72.PubMedCrossRef Ioannou GN, Weiss NS, Kearney DJ. Is Helicobacter pylori seropositivity related to body mass index in the United States? Aliment Pharmacol Ther. 2005;21:765–72.PubMedCrossRef
58.
go back to reference Cho I, Blaser MJ, François F, Mathew JP, Ye XY, Goldberg JD, et al. Helicobacter pylori and overweight status in the United States: data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2005;162:579–84.PubMedCrossRef Cho I, Blaser MJ, François F, Mathew JP, Ye XY, Goldberg JD, et al. Helicobacter pylori and overweight status in the United States: data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2005;162:579–84.PubMedCrossRef
59.
go back to reference Lane JA, Murray LJ, Harvey IM, Donovan JL, Nair P, Harvey RF. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther. 2011;33:922–9.PubMedCrossRef Lane JA, Murray LJ, Harvey IM, Donovan JL, Nair P, Harvey RF. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther. 2011;33:922–9.PubMedCrossRef
60.
go back to reference Jeffery PL, McGuckin MA, Linden SK. Endocrine impact of Helicobacter pylori: focus on ghrelin and ghrelin O-acyltransferase. World J Gastroenterol. 2011;17:1249.PubMedCentralPubMedCrossRef Jeffery PL, McGuckin MA, Linden SK. Endocrine impact of Helicobacter pylori: focus on ghrelin and ghrelin O-acyltransferase. World J Gastroenterol. 2011;17:1249.PubMedCentralPubMedCrossRef
61.
go back to reference Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis. 2008;40:650–8.PubMedCrossRef Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis. 2008;40:650–8.PubMedCrossRef
62.
go back to reference Islami F, Sheikhattari P, Ren JS, Kamangar F. Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma—a systematic review and meta-analysis. Ann Oncol. 2011;22:754–60.PubMedCrossRef Islami F, Sheikhattari P, Ren JS, Kamangar F. Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma—a systematic review and meta-analysis. Ann Oncol. 2011;22:754–60.PubMedCrossRef
63.
go back to reference Alemán JO, Eusebi LH, Ricciardiello L, Patidar K, Sanyal AJ, Holt PR. Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology. 2014;146:357–73.PubMedCrossRef Alemán JO, Eusebi LH, Ricciardiello L, Patidar K, Sanyal AJ, Holt PR. Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology. 2014;146:357–73.PubMedCrossRef
64.
go back to reference Nakajima TE, Yamada Y, Hamano T, Furuta K, Gotoda T, Katai H, et al. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. J Gastroenterol. 2009;44:685–90.PubMedCrossRef Nakajima TE, Yamada Y, Hamano T, Furuta K, Gotoda T, Katai H, et al. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. J Gastroenterol. 2009;44:685–90.PubMedCrossRef
65.
go back to reference Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, Nagawa H. Plasma adiponectin and gastric cancer. Clin Cancer Res. 2005;11:466–72.PubMedCrossRef Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, Nagawa H. Plasma adiponectin and gastric cancer. Clin Cancer Res. 2005;11:466–72.PubMedCrossRef
66.
go back to reference Robertson EV, Derakhshan MH, Wirz AA, Lee YY, Seenan JP, Ballantyne SA, et al. Central obesity in asymptomatic volunteers is associated with increased intrasphincteric acid reflux and lengthening of the cardiac mucosa. Gastroenterology. 2013;145:730–9.PubMedCrossRef Robertson EV, Derakhshan MH, Wirz AA, Lee YY, Seenan JP, Ballantyne SA, et al. Central obesity in asymptomatic volunteers is associated with increased intrasphincteric acid reflux and lengthening of the cardiac mucosa. Gastroenterology. 2013;145:730–9.PubMedCrossRef
67.
go back to reference Quante M, Abrams JA, Wang TC. The rapid rise in gastroesophageal junction tumors: is inflammation of the gastric cardia the underwater iceberg? Gastroenterology. 2013;145:708–22.PubMedCentralPubMedCrossRef Quante M, Abrams JA, Wang TC. The rapid rise in gastroesophageal junction tumors: is inflammation of the gastric cardia the underwater iceberg? Gastroenterology. 2013;145:708–22.PubMedCentralPubMedCrossRef
68.
go back to reference McQuaid KR, Laine L, Fennerty MB, Souza R, Spechler SJ. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther. 2011;34:146–65.PubMedCrossRef McQuaid KR, Laine L, Fennerty MB, Souza R, Spechler SJ. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther. 2011;34:146–65.PubMedCrossRef
69.
go back to reference Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439:484–9.PubMedCrossRef Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439:484–9.PubMedCrossRef
70.
go back to reference Watanabe M, Morimoto K, Houten SM, Kaneko-Iwasaki N, Sugizaki T, Horai Y, et al. Bile acid binding resin improves metabolic control through the induction of energy expenditure. PLoS ONE. 2012;7:e38286.PubMedCentralPubMedCrossRef Watanabe M, Morimoto K, Houten SM, Kaneko-Iwasaki N, Sugizaki T, Horai Y, et al. Bile acid binding resin improves metabolic control through the induction of energy expenditure. PLoS ONE. 2012;7:e38286.PubMedCentralPubMedCrossRef
71.
72.
go back to reference Bowrey DJ, Williams GT, Carey PD, Clark GW. Inflammation at the cardio-oesophageal junction: relationship to acid and bile exposure. Eur J Gastroenterol Hepatol. 2003;15:49–54.PubMedCrossRef Bowrey DJ, Williams GT, Carey PD, Clark GW. Inflammation at the cardio-oesophageal junction: relationship to acid and bile exposure. Eur J Gastroenterol Hepatol. 2003;15:49–54.PubMedCrossRef
Metadata
Title
Obesity and related risk factors in gastric cardia adenocarcinoma
Authors
Sidney Olefson
Steven F. Moss
Publication date
01-01-2015
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 1/2015
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-014-0425-4

Other articles of this Issue 1/2015

Gastric Cancer 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.